China Universal Asset Management Company’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
27,765
+256
| +0.9% | +$1.29K | 0.01% | 339 |
|
|
2025
Q1 | $178K | Sell |
27,509
-1,693
| -6% | -$11K | 0.02% | 322 |
|
|
2024
Q4 | $214K | Buy |
29,202
+2,922
| +11% | +$21.4K | 0.02% | 321 |
|
|
2024
Q3 | $197K | Buy |
26,280
+10,294
| +64% | +$77.1K | 0.02% | 300 |
|
|
2024
Q2 | $142K | Sell |
15,986
-9,988
| -38% | -$88.9K | 0.02% | 274 |
|
|
2024
Q1 | $263K | Buy |
25,974
+10,414
| +67% | +$105K | 0.03% | 257 |
|
|
2023
Q4 | $157K | Buy |
15,560
+12,112
| +351% | +$122K | 0.03% | 231 |
|
|
2023
Q3 | $32.3K | Buy |
3,448
+1,692
| +96% | +$15.9K | 0.01% | 261 |
|
|
2023
Q2 | $43.1K | Sell |
1,756
-53
| -3% | -$1.3K | 0.01% | 206 |
|
|
2023
Q1 | $42.1K | Buy |
1,809
+456
| +34% | +$10.6K | 0.01% | 163 |
|
|
2022
Q4 | $34.2K | Buy |
1,353
+111
| +9% | +$2.81K | 0.01% | 149 |
|
|
2022
Q3 | $24K | Buy |
+1,242
| New | +$24K | 0.01% | 146 |
|